{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:03:11Z","timestamp":1788397391755,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00467-020-04485-8","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:03:06Z","timestamp":1581678186000},"page":"539-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1371-3096","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Seeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Feber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"4485_CR1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","volume":"26","author":"MR Weir","year":"2015","unstructured":"Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A, Mitsnefes MM, Sica DA, Taler SJ (2015) Assessment and management of hypertension in transplant patients. J Am Soc Nephrol 26:1248\u20131260","journal-title":"J Am Soc Nephrol"},{"key":"4485_CR2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF00858130","volume":"8","author":"HJ Baluarte","year":"1994","unstructured":"Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A (1994) Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8:570\u2013573","journal-title":"Pediatr Nephrol"},{"key":"4485_CR3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1681\/ASN.V1061324","volume":"10","author":"JM Sorof","year":"1999","unstructured":"Sorof JM, Sullivan EK, Tejani A, Portman RJ (1999) Antihypertensive medication and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 10:1324\u20131330","journal-title":"J Am Soc Nephrol"},{"key":"4485_CR4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ki.2011.232","volume":"80","author":"AM Kramer","year":"2011","unstructured":"Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, Lewis MA, Boehm M, Simonetti GD, Novljan G, Groothoff JW (2011) Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int 80:1092\u20131098","journal-title":"Kidney Int"},{"key":"4485_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","volume":"53","author":"G Opelz","year":"1998","unstructured":"Opelz G, Wujciak T, Ritz E, Collaborative Transplant Study (1998) Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217\u2013222","journal-title":"Kidney Int"},{"key":"4485_CR6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","volume":"283","author":"KC Mange","year":"2000","unstructured":"Mange KC, Gizman B, Joffe M, Feldman HI (2000) Arterial hypertension and renal allograft survival. JAMA 283:633\u2013638","journal-title":"JAMA"},{"key":"4485_CR7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3046.2001.t01-1-00051.x","volume":"5","author":"MM Mitsnefes","year":"2001","unstructured":"Mitsnefes MM, Omoloja A, McEnery PT (2001) Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transpl 5:160\u2013165","journal-title":"Pediatr Transpl"},{"key":"4485_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(03)00209-9","volume":"143","author":"MM Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Khoury PR, McEnery PT (2003) Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98\u2013103","journal-title":"J Pediatr"},{"key":"4485_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ajh\/hpx092","volume":"30","author":"G Hamdani","year":"2017","unstructured":"Hamdani G, Nehus EJ, Hanevold CD, VanSickle JS, Hooper DK, Blowey D, Warady BA, Mitsnefes MM (2017) Ambulatory blood pressure control in children and young adults after kidney transplantation. Am J Hypertens 30:1039\u20131046","journal-title":"Am J Hypertens"},{"key":"4485_CR10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00467-007-0627-7","volume":"24","author":"T Seeman","year":"2009","unstructured":"Seeman T (2009) Hypertension after renal transplantation. Pediatr Nephrol 24:959\u2013972","journal-title":"Pediatr Nephrol"},{"key":"4485_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-3046.2006.00595.x","volume":"11","author":"JR Ferraris","year":"2007","unstructured":"Ferraris JR, Ghezzi L, Waisman G, Krmar RT (2007) ABPM vs. office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplantation 11:24\u201330","journal-title":"Pediatr Transplantation"},{"key":"4485_CR12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0272-6386(00)70016-3","volume":"35","author":"JM Sorof","year":"2000","unstructured":"Sorof JM, Poffenbarger T, Portman R (2000) Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis 35:681\u2013686","journal-title":"Am J Kidney Dis"},{"key":"4485_CR13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s004670100668","volume":"16","author":"H Morgan","year":"2001","unstructured":"Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW (2001) Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 16:843\u2013847","journal-title":"Pediatr Nephrol"},{"key":"4485_CR14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1399-3046.2005.00353.x","volume":"9","author":"E Serdaroglu","year":"2005","unstructured":"Serdaroglu E, Mir S, Berdelli A (2005) Hypertension and ACE gene insertion\/deletion polymorphism in pediatric renal transplant patients. Pediatr Transplant 9:612\u2013617","journal-title":"Pediatr Transplant"},{"key":"4485_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3046.2005.00468.x","volume":"10","author":"T Seeman","year":"2006","unstructured":"Seeman T, \u0160imkov\u00e1 E, Kreisinger J, Vondr\u00e1k K, Du\u0161ek J, Gil\u00edk J, Feber J, Dvo\u0159\u00e1k P, Janda J (2006) Control of hypertension in children after renal transplantation. Pediatr Transplant 10:316\u2013322","journal-title":"Pediatr Transplant"},{"key":"4485_CR16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-3046.2006.00521.x","volume":"10","author":"KR McGlothan","year":"2006","unstructured":"McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP (2006) Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant 10:558\u2013564","journal-title":"Pediatr Transplant"},{"key":"4485_CR17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ajh\/hpt140","volume":"27","author":"C Cameron","year":"2014","unstructured":"Cameron C, Vavilis G, Kowalski J, Tyd\u00e9n G, Berg UB, Krmar RT (2014) An observational cohort study of the effect of hypertension on the loss of renal function in pediatric kidney recipients. Am J Hypertens 27:579\u2013585","journal-title":"Am J Hypertens"},{"key":"4485_CR18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/TP.0000000000001087","volume":"101","author":"G Hamdani","year":"2017","unstructured":"Hamdani G, Nehus EJ, Hanevold CD, Sebestyen Van Sickle J, Woroniecki R, Wenderfer SE, Hooper DK, Blowey D, Wilson A, Warady BA, Mitsnefes MM (2017) Ambulatory blood pressure, left ventricular hypertrophy, and allograft function in children and young adults after kidney transplantation. Transplantation 101:150\u2013156","journal-title":"Transplantation"},{"key":"4485_CR19","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/petr.13329","volume":"23","author":"T Seeman","year":"2019","unstructured":"Seeman T, Vondr\u00e1k K, Du\u0161ek J (2019) Effects of the strict control of blood pressure in pediatric renal transplant recipients\u2014ESCORT trial. Pediatr Transplant Febr 23:e13329","journal-title":"Pediatr Transplant Febr"},{"key":"4485_CR20","first-page":"S1","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant Suppl 3:S1\u2013S155","journal-title":"Am J Transplant Suppl"},{"key":"4485_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2012) KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2:337\u2013414","journal-title":"Kidney Int Suppl"},{"key":"4485_CR22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/j.ajkd.2014.03.003","volume":"63","author":"M Ruzicka","year":"2014","unstructured":"Ruzicka M, Quinn RR, McFarlane P, Hemmelgarn B, Ramesh Prasad GV, Feber J, Nesrallah G, MacKinnon M, Tangri N, McCormick B, Tobe S, Blydt-Hansen TD, Hiremath S (2014) Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD. Am J Kidney Dis 63:869\u2013887","journal-title":"Am J Kidney Dis"},{"key":"4485_CR23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","volume":"4","author":"GA Knoll","year":"2016","unstructured":"Knoll GA, Fergusson D, Chass\u00e9 M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J (2016) Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 4:318\u2013326","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4485_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/TP.0b013e3181a9e960","volume":"88","author":"NB Cross","year":"2009","unstructured":"Cross NB, Webster AC, Masson P, O'connell PJ, Craig JC (2009) Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. Transplantation 88:7\u201318","journal-title":"Transplantation"},{"key":"4485_CR25","doi-asserted-by":"publisher","unstructured":"Pisano A, Bolignano D, Mallamaci F, D'Arrigo G, Halimi JM, Persu A, Wuerzner G, Sarafidis P, Watschinger B, Burnier M, Zoccali C (2019) Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfz092","DOI":"10.1093\/ndt\/gfz092"},{"key":"4485_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","volume":"72","author":"K Midtvedt","year":"2001","unstructured":"Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001) Reduction of left ventricular mass by lisinopril and nifedipin in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 72:107\u2013111","journal-title":"Transplantation"},{"key":"4485_CR27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1399-3046.2009.01216.x","volume":"14","author":"T Seeman","year":"2010","unstructured":"Seeman T, Dusek J, Vondr\u00e1k K, Janda J (2010) Ramipril in the treatment of proteinuria in children after renal transplantation. Pediatr Transplant 14:283\u2013287","journal-title":"Pediatr Transplant"},{"key":"4485_CR28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1034\/j.1399-3046.1999.00056.x","volume":"3","author":"DM Silverstein","year":"1999","unstructured":"Silverstein DM, Palmer J, Baluarte HJ, Brass C, Conley SB, Polinsky MS (1999) Use of calcium-channel blockers in pediatric renal transplant recipients. Pediatr Transplant 3:288\u2013292","journal-title":"Pediatr Transplant"},{"key":"4485_CR29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s004670000400","volume":"14","author":"JW Rogan","year":"2000","unstructured":"Rogan JW, Lyszkiewicz DA, Blowey D, Khattak S, Arbus GS, Koren G (2000) A randomized prospective crossover trial of amlodipin in pediatric hypertension. Pediatr Nephrol 14:1083\u20131087","journal-title":"Pediatr Nephrol"},{"key":"4485_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00467-003-1317-8","volume":"19","author":"K Arbeiter","year":"2004","unstructured":"Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C (2004) ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 19:222\u2013226","journal-title":"Pediatr Nephrol"},{"key":"4485_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ctr.12125","volume":"27","author":"TM Suszynski","year":"2013","unstructured":"Suszynski TM, Rizzari MD, Gillingham KJ, Rheault MN, Kraszkiewicz W, Matas AJ, Chavers BM (2013) Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation. Clin Transpl 27:472\u2013480","journal-title":"Clin Transpl"},{"key":"4485_CR32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","volume":"17","author":"G Heinze","year":"2006","unstructured":"Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R (2006) Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17:889\u2013899","journal-title":"J Am Soc Nephrol"},{"key":"4485_CR33","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","volume":"17","author":"G Opelz","year":"2006","unstructured":"Opelz G, Zeier M, Laux G, Morath C, Dohler B (2006) No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a Collaborative Transplant Study report. J Am Soc Nephrol 17:3257\u20133262","journal-title":"J Am Soc Nephrol"},{"key":"4485_CR34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/1060028019843644","volume":"53","author":"TD Steuber","year":"2019","unstructured":"Steuber TD, Lee J, Holloway A, Andrus MR (2019) Nondihydropyridine calcium channel blockers for the treatment of proteinuria: a review of the literature. Ann Pharmacother 53:1050\u20131059","journal-title":"Ann Pharmacother"},{"key":"4485_CR35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1179\/acb.2004.007","volume":"59","author":"A Derwa","year":"2004","unstructured":"Derwa A, Peeters P, Vanholder R (2004) Calcium channel blockers in the prevention of end stage renal disease: a review. Acta Clin Belg 59:44\u201356","journal-title":"Acta Clin Belg"},{"issue":"3 Suppl","key":"4485_CR36","first-page":"S85","volume":"6","author":"DA Sica","year":"2000","unstructured":"Sica DA (2000) Class effects of angiotensin-converting enzyme inhibitors. Am J Manag Care 6(3 Suppl):S85\u2013S108","journal-title":"Am J Manag Care"},{"issue":"39","key":"4485_CR37","doi-asserted-by":"crossref","first-page":"e1560","DOI":"10.1097\/MD.0000000000001560","volume":"94","author":"R Xu","year":"2015","unstructured":"Xu R, Sun S, Huo Y, Yun L, Huang S, Li G, Yan S (2015) Effects of ACEIs versus ARBs on proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials. Medicine (Baltimore) 94(39):e1560","journal-title":"Medicine (Baltimore)"},{"key":"4485_CR38","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, W\u00fchl E, Zanchetti A (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887\u20131920","journal-title":"J Hypertens"},{"key":"4485_CR39","doi-asserted-by":"publisher","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on screening and management of high blood pressure in children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140. https:\/\/doi.org\/10.1542\/peds.2017-1904","DOI":"10.1542\/peds.2017-1904"},{"key":"4485_CR40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","volume":"43","author":"P Ruggenenti","year":"1993","unstructured":"Ruggenenti P, Perna A, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G (1993) Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43:706\u2013711","journal-title":"Kidney Int"},{"issue":"Suppl 63","key":"4485_CR41","first-page":"S75","volume":"52","author":"JJ Curtis","year":"1997","unstructured":"Curtis JJ (1997) Treatment of hypertension in renal allograft patients: does drug selection make a difference. Kidney Int 52(Suppl 63):S75\u2013S77","journal-title":"Kidney Int"},{"key":"4485_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cpt.127","volume":"98","author":"H Trachtman","year":"2015","unstructured":"Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee (2015) Pharmacokinetics, pharmacodynamics, and safety of lisinopril in pediatric kidney transplant patients: implications for starting dose selection. Clin Pharmacol Ther 98:25\u201333","journal-title":"Clin Pharmacol Ther"},{"key":"4485_CR43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","volume":"35","author":"CE Stigant","year":"2000","unstructured":"Stigant CE, Cohen J, Vivera M, Zaltzman JS (2000) ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 35:58\u201363","journal-title":"Am J Kidney Dis"},{"key":"4485_CR44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1399-3046.2006.00661.x","volume":"11","author":"T Seeman","year":"2007","unstructured":"Seeman T, Simkov\u00e1 E, Kreisinger J, Vondr\u00e1k K, Dusek J, Gil\u00edk J, Dvor\u00e1k P, Janda J (2007) Improved control of hypertension in children after renal transplantation: results of a two-yr interventional trial. Pediatr Transplant 11:491\u2013497","journal-title":"Pediatr Transplant"},{"key":"4485_CR45","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors\/Task Force Members (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 36:1953\u20132041","journal-title":"J Hypertens"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-020-04485-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:16:28Z","timestamp":1695766588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-020-04485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4485"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04485-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}